| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | France Légaré | Q28324521 |
| Jean-Claude Forest | Q84761071 | ||
| Emmanuel Bujold | Q88794384 | ||
| P2093 | author name string | François Rousseau | |
| Nathalie Bernard | |||
| Yves Giguère | |||
| Marc Charland | |||
| Sonya Grenier | |||
| Julie Lafond | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pre-eclampsia | Q61335 |
| systematic review | Q1504425 | ||
| P304 | page(s) | 361-375 | |
| P577 | publication date | 2009-12-31 | |
| P1433 | published in | Clinical Chemistry | Q849687 |
| P1476 | title | Combining biochemical and ultrasonographic markers in predicting preeclampsia: a systematic review | |
| P478 | volume | 56 |
| Q37158028 | (Epi)genetics of pregnancy-associated diseases |
| Q34523176 | A cohort evaluation on arterial stiffness and hypertensive disorders in pregnancy |
| Q35560725 | ADAM12 produced by tumor cells rather than stromal cells accelerates breast tumor progression |
| Q34714082 | Angiogenic factors and preeclampsia |
| Q43813575 | Association between physical activity in early pregnancy and markers of placental growth and function |
| Q35756049 | Biochemical markers for prediction of preclampsia: review of the literature. |
| Q46306526 | Blood laboratory testing for early prediction of preeclampsia: chasing the finish line or at the starting blocks? |
| Q33923716 | Can changes in angiogenic biomarkers between the first and second trimesters of pregnancy predict development of pre-eclampsia in a low-risk nulliparous patient population? |
| Q44235867 | Classification of cardiovascular time series based on different coupling structures using recurrence networks analysis. |
| Q34919926 | Diagnosis and management of fetal growth restriction |
| Q34345684 | Diagnosis and management of pre-eclampsia: an update |
| Q47243601 | Early second-trimester maternal serum markers in prediction of gestational diabetes mellitus |
| Q46325309 | Economic assessment of screening for pre-eclampsia |
| Q38868475 | Etiopathogenesis, prediction, and prevention of preeclampsia |
| Q58035911 | External validation, update and development of prediction models for pre-eclampsia using an Individual Participant Data (IPD) meta-analysis: the International Prediction of Pregnancy Complication Network (IPPIC pre-eclampsia) protocol |
| Q38020351 | First trimester serum markers to predict preeclampsia |
| Q33955769 | First trimester uterine artery Doppler for the prediction of preeclampsia and foetal growth restriction |
| Q53492565 | First-trimester 3-dimensional power Doppler placental vascularization indices from the whole placenta versus the placental bed to predict preeclampsia: does pregnancy-associated plasma protein a or uterine artery Doppler sonography help? |
| Q89684234 | First-trimester maternal serum alpha-fetoprotein is not a good predictor for adverse pregnancy outcomes: a retrospective study of 3325 cases |
| Q47604074 | High first-trimester maternal blood cystatin C levels despite normal serum creatinine predict pre-eclampsia in singleton pregnancies. |
| Q89347707 | Hypertensive Disorders of Pregnancy |
| Q37121846 | Maternal Nodal inversely affects NODAL and STOX1 expression in the fetal placenta |
| Q26799339 | Novel Electrocardiographic Patterns for the Prediction of Hypertensive Disorders of Pregnancy--From Pathophysiology to Practical Implications |
| Q46301536 | Podocyturia as an early diagnostic marker of preeclampsia: a literature review |
| Q97540484 | Potential Protein Biomarkers for Preeclampsia |
| Q46322861 | Prediction of preeclampsia by combining serum histidine-rich glycoprotein and uterine artery Doppler |
| Q53344481 | Preeclampsia is associated with an elevation of plasma sMet concentrations in the second trimester. |
| Q39742935 | Prevention of adverse pregnancy outcomes with low-dose ASA in early pregnancy: new perspectives for future randomized trials. |
| Q84865103 | Prevention of perinatal death with low-dose aspirin in developing countries |
| Q58911049 | Prevention of preeclampsia |
| Q38543855 | Pulsatility index in combination with biomarkers or mean arterial pressure for the prediction of pre-eclampsia: Systematic literature review and meta-analysis |
| Q34284028 | SMAD1/5 signaling in the early equine placenta regulates trophoblast differentiation and chorionic gonadotropin secretion. |
| Q34735623 | STOX1: Key player in trophoblast dysfunction underlying early onset preeclampsia with growth retardation |
| Q50638104 | Screening for pre-eclampsia early in pregnancy: performance of a multivariable model combining clinical characteristics and biochemical markers. |
| Q37919093 | Screening for pre-eclampsia: a systematic review of tests combining uterine artery Doppler with other markers. |
| Q57671239 | Serum hyperglycosylated human chorionic gonadotrophin at 14-17 weeks of gestation does not predict preeclampsia |
| Q38034803 | Serum uric acid and pre-eclampsia: an update |
| Q35574857 | TNF-R1 as a first trimester marker for prediction of pre-eclampsia |
| Q47109831 | The pregnancy outcome prediction (POP) study: Investigating the relationship between serial prenatal ultrasonography, biomarkers, placental phenotype and adverse pregnancy outcomes. |
| Q87427787 | The use of pulse wave velocity in predicting pre-eclampsia in high-risk women |
| Q36253829 | The utility of uterine artery Doppler velocimetry in prediction of preeclampsia in a low-risk population |
| Q33786230 | The vitamin E-binding protein afamin increases in maternal serum during pregnancy |
| Q96816256 | Tracking placental development in health and disease |
| Q57395707 | βhCG and PAPP-A in First Trimester: Predictive Factors for Preeclampsia? |
Search more.